drugset / Trial / NCT00901368

FACTO Study (Foster® As Complete Treatment Option)

NCT00901368

Phase 4 Completed 431 enrolled Chiesi Farmaceutici S.p.A.
RandomizedParallel-groupDouble-blindTreatment

Summary

Double blind, multinational, multicentre, randomised, 2 arm parallel group study

Timeline

Start
2009-05
Primary completion
2010-09
Completion
2010-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Fluticasone Other / unclassified 500 ug Inhaled
Subject Formoterol Other / unclassified 24 ug Inhaled
Subject Salmeterol Other / unclassified 100 ug Inhaled
Subject beclomethasone dipropionate Other / unclassified 400 ug Inhaled

Indications